Cargando…

Medication Therapy Management Versus Drug Regimen Review

Detalles Bibliográficos
Autor principal:	Summers, Kent H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2007
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10438360/ https://www.ncbi.nlm.nih.gov/pubmed/17269840 http://dx.doi.org/10.18553/jmcp.2007.13.1.68

Ejemplares similares

Pharmaceutical Manufacturer Prescription Assistance Programs: Are They Worth It?
por: Chen, Judy T., et al.
Publicado: (2007)

Challenges and Opportunities in Pharmacogenomics and Therapeutics
por: Kane, Michael D., et al.
Publicado: (2007)

Selecting Insulin Regimens for the Management of Non-ICU Patients With Type 2 Diabetes
por: Migdal, Alexandra L, et al.
Publicado: (2021)

Incretin Therapy and Pancreatic Pathologies: Background Pathology Versus Drug-Induced Pathology in Rats
por: Egan, Josephine M., et al.
Publicado: (2014)

Medication Therapy Management Programs: When Will the Outcomes Come Out?
por: Spooner, Joshua J.
Publicado: (2007)

Uterine Fibroids: A Podcast on Patient and Physician Perspectives on Medical Management and a New Medical Therapy (Relugolix Combination Therapy)
por: Venable, Sateria R., et al.
Publicado: (2023)

Tailoring management and immunosuppression regimen in kidney transplant recipients with COVID-19 infection: lessons from Singapore
por: Chang, Zi Yun, et al.
Publicado: (2021)

Comments on the optimal use of medical ozone in clinics versus the Ozone High Dose Therapy (OHT) approach
por: Franzini, Marianno, et al.
Publicado: (2022)

Toward effective hematopoietic stem cell gene therapies: Optimized conditioning regimen and stem cell source in harmony
por: Demirci, Selami, et al.
Publicado: (2023)

Market-driven, value-based, advance commitment (MVAC): accelerating the development of a pathbreaking universal drug regimen to end TB
por: Chalkidou, Kalipso, et al.
Publicado: (2020)

The adjuvant regimen for resected EGFR mutated patients: the “same-for-all-therapy” or not?
por: Gridelli, Cesare, et al.
Publicado: (2020)

Medical education in Malaysia: quality versus quantity
por: Wong, Rebecca S. Y., et al.
Publicado: (2017)

Medication Therapy Management Favors Large Pharmacy Chains and Creates Potential Conflicts of Interest
por: Cook, Daniel M., et al.
Publicado: (2009)

Clinical Outcomes of Patients With Drug-Resistant Tuberculous Meningitis Treated With an Intensified Antituberculosis Regimen
por: Heemskerk, A Dorothee, et al.
Publicado: (2017)

Medication Risk Management
por: Mohiuddin, AK
Publicado: (2019)

Shortened treatment regimens versus the standard regimen for drug‐sensitive pulmonary tuberculosis
por: Grace, Angeline G, et al.
Publicado: (2019)

Opioid Use Disorders in People Living with HIV/AIDS: A Review of Implications for Patient Outcomes, Drug Interactions, and Neurocognitive Disorders
por: Cernasev, Alina, et al.
Publicado: (2020)

Medical heuristics and action-research: professionalism versus science
por: Unger, Jean-Pierre, et al.
Publicado: (2020)

Identifying the Right Target for New Drugs in Acute Kidney Injury: A Long Way Off?
por: Doi, Kent
Publicado: (2023)

Open-Angle Glaucoma: Burden of Illness, Current Therapies, and the Management of Nocturnal IOP Variation
por: Sheybani, Arsham, et al.
Publicado: (2019)

Review of Regulatory Programs and New Opioid Technologies in Chronic Pain Management: Balancing the Risk of Medication Abuse with Medical Need
por: Fishbain, David, et al.
Publicado: (2010)

Erratum to: Medication Risk Management
por: Mohiuddin, AK
Publicado: (2020)

Improving Multiple Sclerosis Care: An Analysis of the Necessity for Medication Therapy Management Services Among the Patient Population
por: Anderson, Sarah Shore, et al.
Publicado: (2014)

Comparing the Efficacy of Drug Regimens for Pulmonary Tuberculosis: Meta-analysis of Endpoints in Early-Phase Clinical Trials
por: Bonnett, Laura J, et al.
Publicado: (2017)

Intensity modulated radiation therapy versus volumetric intensity modulated arc therapy
por: Rana, Suresh
Publicado: (2013)

The Limits of Two-Year Bioassay Exposure Regimens for Identifying Chemical Carcinogens
por: Huff, James, et al.
Publicado: (2008)

Narcotic-based sedation regimens for critically ill mechanically ventilated patients
por: Pandharipande, Pratik, et al.
Publicado: (2005)

Metronidazole; a Potential Novel Addition to the COVID-19 Treatment Regimen
por: Gharebaghi, Reza, et al.
Publicado: (2020)

Expanding the National Drug Abuse Treatment Clinical Trials Network to address the management of substance use disorders in general medical settings
por: Tai, Betty, et al.
Publicado: (2014)

Non-inferiority versus superiority drug claims: the (not so) subtle distinction
por: Ganju, Jitendra, et al.
Publicado: (2017)

The strange history of phage therapy
por: Summers, William C.
Publicado: (2012)

Managing Heterogeneity in Prescription Drug Coverage Policies
por: Teagarden, J. Russell
Publicado: (2014)

Drug safety: withdrawn medications are only part of the picture
por: Rawson, Nigel S. B.
Publicado: (2016)

Medical students’ intrinsic versus extrinsic motivation to engage in research as preparation for residency
por: Ommering, Belinda W. C., et al.
Publicado: (2017)

Optimal vasopressor drug therapy during resuscitation
por: Ornato, Joseph P
Publicado: (2008)

Repurposing an HIV Drug for Zika Virus Therapy
por: Xie, Xuping, et al.
Publicado: (2019)

Risk Management in Drug-Device Combination Product Development
por: Kumoluyi, Robin, et al.
Publicado: (2022)

Statins and therapy of Alzheimer's disease: questions of efficacy versus trial design
por: Wolozin, Benjamin
Publicado: (2012)

Is the efficacy of psychopharmacological drugs comparable to the efficacy of general medicine medication?
por: Seemüller, Florian, et al.
Publicado: (2012)

Nonmedical Use of Prescription Drugs among Medical Students and the Relationship With Illicit Drug, Tobacco, and Alcohol Use
por: Papazisis, Georgios, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_qbscfqo7qkfb0b6ounnp10ra0l